Frovatriptan Succinate
CAS 158930-17-7 3 FDA-DMF suppliersSmall Molecule
Overview
Frovatriptan Succinate is a selective 5-HT receptor agonist used to treat migraine attacks. It has a higher affinity for the 5-HT1B and 5-HT1D receptors, contributing to its efficacy in alleviating headache symptoms.
Therapeutic areas
NeurologyPain Management
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.